KLAQ
KL Acquisition Corp [KLAQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
KLAQ Stock Summary
In the News
KLAQ Financial details
Company Rating
Neutral
Market Cap
0
Income
16.99M
Revenue
0
Book val./share
-1.45
Cash/share
40.25
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2021
P/E
5.91
Forward P/E
-
PEG
-
P/S
-
P/B
-6.95
P/C
-
P/FCF
-
Quick Ratio
596.59
Current Ratio
0.25
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.2
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
60%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
4%
ROE
7%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.71-10.105
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
102.54K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
KLAQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2020-12-31 | 2021-12-31 |
|---|---|---|---|
| 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | |
| Net income per share | 0 | 2.78 | |
| Operating cash flow per share | 0 | -0.13 | |
| Free cash flow per share | 0 | -0.13 | |
| Cash per share | 0 | 0.08 | |
| Book value per share | 0 | 37.6 | |
| Tangible book value per share | 0 | 37.6 | |
| Share holders equity per share | 0 | 37.6 | |
| Interest debt per share | 0 | -0.09 | |
| Market cap | 359.37M | 70.44M | |
| Enterprise value | 359.53M | 69.89M | |
| P/E ratio | 0 | 3.52 | |
| Price to sales ratio | 0 | 0 | |
| POCF ratio | 0 | -74.78 | |
| PFCF ratio | 0 | -74.78 | |
| P/B Ratio | -7.66K | 0.26 | |
| PTB ratio | -7.66K | 0.26 | |
| EV to sales | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 7.55 | |
| EV to operating cash flow | 0 | -74.2 | |
| EV to free cash flow | 0 | -74.2 | |
| Earnings yield | 0 | 0.28 | |
| Free cash flow yield | 0 | -0.01 | |
| Debt to equity | -3.24 | 0 | |
| Debt to assets | 0.37 | 0 | |
| Net debt to EBITDA | 0 | -0.06 | |
| Current ratio | 0 | 3.18 | |
| Interest coverage | 0 | 1.32 | |
| Income quality | 0 | -0.1 | |
| Dividend Yield | 0 | 0 | |
| Payout ratio | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | |
| Capex to revenue | 0 | 0 | |
| Capex to depreciation | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | |
| Graham number | 0 | 48.51 | |
| ROIC | 0 | -0.01 | |
| Return on tangible assets | 0 | 0.07 | |
| Graham Net | -0.01 | -2.45 | |
| Working capital | -303.1K | 582.58K | |
| Tangible asset value | -46.93K | 270.26M | |
| Net current asset value | -455.13K | -17.31M | |
| Invested capital | -3.24 | 0 | |
| Average receivables | 0 | 0 | |
| Average payables | 0 | 61.56K | |
| Average inventory | 0 | 0 | |
| Days sales outstanding | 0 | 0 | |
| Days payables outstanding | 0 | 53.94 | |
| Days of inventory on hand | 0 | 0 | |
| Receivables turnover | 0 | 0 | |
| Payables turnover | 0 | 6.77 | |
| Inventory turnover | 0 | 0 | |
| ROE | 0 | 0.07 | |
| Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0.49 | 1.19 | 0.2 | 0.32 | |
| Operating cash flow per share | 0 | -0.01 | -0.05 | -0.02 | -0.01 | |
| Free cash flow per share | 0 | -0.01 | -0.05 | -0.02 | -0.01 | |
| Cash per share | 0 | 0.06 | 0.03 | 0.01 | 40.25 | |
| Book value per share | 0 | 28.37 | 38.18 | 38.38 | -1.45 | |
| Tangible book value per share | 0 | 28.37 | 38.18 | 38.38 | 38.69 | |
| Share holders equity per share | 0 | 28.37 | 38.18 | 38.38 | -1.45 | |
| Interest debt per share | 0 | -0.07 | 0 | 0.05 | -0.39 | |
| Market cap | 0 | 93.36M | 70.44M | 70.73M | 71.08M | |
| Enterprise value | -671.3K | 92.81M | 70.25M | 70.65M | 71.06M | |
| P/E ratio | 0 | 4.96 | 2.05 | 12.47 | 7.76 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | -769.63 | -193.34 | -634.86 | -1.31K | |
| PFCF ratio | 0 | -769.63 | -193.34 | -634.86 | -1.31K | |
| P/B Ratio | 0 | 0.35 | 0.26 | 0.26 | -6.81 | |
| PTB ratio | 0 | 0.35 | 0.26 | 0.26 | -6.81 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 49.11 | 16.83 | 38.28 | 27.84 | |
| EV to operating cash flow | 0 | -765.1 | -192.83 | -634.19 | -1.31K | |
| EV to free cash flow | 0 | -765.1 | -192.83 | -634.19 | -1.31K | |
| Earnings yield | 0 | 0.05 | 0.12 | 0.02 | 0.03 | |
| Free cash flow yield | 0 | 0 | -0.01 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | -0.29 | -0.04 | -0.04 | -0.01 | |
| Current ratio | 3.99 | 3.18 | 3.52 | 1.74 | 0.25 | |
| Interest coverage | 0 | 0.33 | -8.69 | -0.47 | 0.08 | |
| Income quality | 0 | -0.05 | -0.09 | -0.08 | -0.02 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 17.76 | 32 | 13.05 | 3.23 | |
| ROIC | 0 | 0 | 0 | 0 | 0.02 | |
| Return on tangible assets | 0 | 0.02 | 0.03 | 0 | 0.01 | |
| Graham Net | 0 | -1.85 | -1.87 | -1.72 | 38.68 | |
| Working capital | 739.27K | 582.58K | 335.82K | 112.86K | -365.98K | |
| Tangible asset value | 267.68M | 270.26M | 274.41M | 275.83M | 278.12M | |
| Net current asset value | -19.97M | -17.31M | -13.19M | -12.16M | -11.17M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 140.51K | 61.56K | 103.14K | 48.64K | 23.85K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 29.74 | 6.92 | 13.95 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 3.03 | 13.01 | 6.45 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0.02 | 0.03 | 0.01 | -0.22 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
KLAQ Frequently Asked Questions
What is KL Acquisition Corp stock symbol ?
KL Acquisition Corp is a US stock , located in New york of Ny and trading under the symbol KLAQ
What is KL Acquisition Corp stock quote today ?
KL Acquisition Corp stock price is $- today.
Is KL Acquisition Corp stock public?
Yes, KL Acquisition Corp is a publicly traded company.
Company Profile
- Volume Average 102.54K
- CEO Mr. Richard Gumer
- Headquarters New York,NY,US
- IPO Date 2021-03-01
KL Acquisition Corp is a blank check company. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus investment effort on life sciences, which includes medical devices, diagnostics, and life sciences tools and instrumentation. The company was incorporated in 2020 and is based in New York, New York.
